An estimate of lifelong costs and QALYs in renal replacement therapy based on patients' life expectancy

Nick Kontodimopoulos and Dimitris Niakas

Health Policy, 2008, vol. 86, issue 1, 85-96

Abstract: Objectives To estimate lifelong costs and quality adjusted life years (QALYs) of hemodialysis (HD), peritoneal dialysis (PD) and renal transplantation (Tx) in Greece, based on individual patient life expectancy.Methods A nationally representative patient sample on each modality, HD: NÂ =Â 642, PD: NÂ =Â 65 and Tx: NÂ =Â 167, was self-administered the SF-36 Health Survey, from which the preference-based SF-6D utility index was derived. Lifelong QALYs were estimated from literature-based expected remaining life years according to age, gender and modality. Cost analyses were performed from the perspective of the health system. Costs and QALYs were discounted at 5% and sensitivity analyses were performed.Results Estimated lifelong QALYs were 4.37 (HD), 3.94 (PD) and 16.11 (Tx) (PÂ

Date: 2008
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (6)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168-8510(07)00230-8
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:86:y:2008:i:1:p:85-96

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().